Log in
Enquire now
EG 427

EG 427

Genetic medicines developer for prevalent chronic diseases in neurology.

OverviewStructured DataIssuesContributors

Contents

eg427.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Regenerative medicine
Regenerative medicine
Manufacturing
Manufacturing
Engineering
Engineering
Biotechnology
Biotechnology
Healthcare
Healthcare
Health technology
Health technology
Tissue engineering
Tissue engineering
Location
France
France
Paris
Paris
CEO
Founder
Pitchbook URL
pitchbook.com/profiles...462125-62
Number of Employees (Ranges)
11 – 50
Founded Date
January 1, 2019
Total Funding Amount (USD)
19,600,000
Latest Funding Round Date
July 13, 2023
Latest Funding Type
Series A
Series A
Country
France
France
Headquarters
Paris
Paris

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
5,600,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like EG 427

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.